U.S. Patent Office Issues Patents in NeuroHealing’s NH004 Program
Newton, Massachusetts – September 2016. NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds, announces that the United States Patent and Trademark Office (USPTO) has issued to NeuroHealing two patents entitled ““Methods and Compositions for Decreasing Saliva Production.” The first patent (US 9,198,897), with a…